-
November 5, 2009
Experimental vaccine cures pre-cancer vulvar growths
BOSTON (Reuters) - An experimental vaccine cured nearly half of women with pre-cancerous growths on their genitals, producing major improvement in nearly four out of five, researchers in the Netherlands reported on Wednesday.
-
November 2, 2009
Many doctors overuse Pap testing: survey
NEW YORK (Reuters Health) - Many U.S. primary care doctors are out of step with guidelines on Pap testing for cervical cancer -- largely because they overuse the test, according to a study published Monday.
-
October 21, 2009
US advisers decline to push Gardasil for boys
WASHINGTON (Reuters) - U.S. vaccine advisers on Wednesday declined to press for the use of Merck & Co's Gardasil in boys and men, opting instead for "permissive" use.
-
October 21, 2009
U.S. backs vaccines for drug, nicotine addiction
CHICAGO (Reuters) - Hooked on cocaine or cigarettes? The U.S. government wants drug companies to make a vaccine for that.
-
October 20, 2009
Free HPV vaccine curbs new cases of genital warts
NEW YORK (Reuters Health) - Since 2007, when free vaccination against HPV for young women became available, Australia has seen a rapid decline in new cases of genital warts, researchers say. HPV, or human papillomavirus, causes genital warts and cervical cancer.
-
October 9, 2009
Giving Gardasil to boys not cost effective: study
CHICAGO (Reuters) - Vaccinating boys against the virus that causes cervical cancer and genital warts does not appear to be cost-effective, U.S. researchers said on Thursday.
-
October 1, 2009
Cancer not cervical cancer vaccine killed UK teen
LONDON (Reuters) - The teenage girl who died shortly after being immunised against cervical cancer was killed by a malignant chest tumour and not by a reaction to the vaccine manufactured by GlaxoSmithKline, an inquest heard on Thursday.
-
September 29, 2009
Girl dies after receiving cervical cancer vaccine
LONDON (Reuters) - A teenage British girl died after receiving a cervical cancer vaccine made by GlaxoSmithKline, health officials said on Monday.
-
September 22, 2009
Experts say cancer wave threatens poorer nations
BERLIN (Reuters) - Cancer is a bigger killer in developing countries than tuberculosis, malaria and AIDS combined and a "tsunami" of the disease threatens to overwhelm the nations worst equipped to cope, experts said on Tuesday.
-
September 22, 2009
Heat-treated tumors respond better to chemotherapy
BERLIN (Reuters) - Cancer patients whose tumors are targeted with heat treatment as well as chemotherapy are more likely to stay alive and cancer-free for longer than those who receive only chemotherapy, researchers said on Tuesday.
-
September 21, 2009
Minorities may shun cervical cancer vaccine
NEW YORK (Reuters Health) - Strong cultural beliefs and limited awareness may lead mothers from certain ethnic groups to choose not to have their daughters vaccinated against human papillomavirus (HPV), the virus responsible for most cases of cervical cancer, according to a study conducted in the UK.
-
September 10, 2009
U.S. panel backs HPV vaccine for males
GAITHERSBURG, Maryland (Reuters) - Merck & Co's cervical cancer vaccine is safe and effective for preventing genital warts in males ages 9 to 26, a U.S. advisory panel said on Wednesday.
-
September 9, 2009
US FDA panel backs Glaxo cervical cancer vaccine
GAITHERSBURG, Md.(Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday.
-
September 7, 2009
Virus might be one cause of prostate cancer-study
WASHINGTON (Reuters) - A virus known to cause leukemia and tumors in animals can be found in some prostate tumors and might be one cause of prostate cancer, U.S. researchers reported on Monday.
-
September 3, 2009
Diabetic women get fewer Pap smears, mammograms
NEW YORK (Reuters Health) - Women with diabetes are less likely to get important cancer screening tests than women without diabetes, new research from Spain confirms.
-
August 25, 2009
Virus blamed for half of penile cancers
LONDON (Reuters) - A sexually transmitted virus that causes cervical cancer is also to blame for half of all cases of cancer of the penis, Spanish researchers said on Tuesday.
-
August 20, 2009
U.S. health officials back safety of Gardasil
WASHINGTON (Reuters) - Merck & Co Inc's vaccine to prevent cervical cancer remains safe and effective, U.S. health officials said on Thursday.
-
August 18, 2009
US researchers see few serious reactions to HPV vaccine
WASHINGTON (Reuters) - Adverse events like fainting or nausea remain rare among young women and girls given Merck and Co's Gardasil vaccine against cervical cancer, U.S. researchers reported on Tuesday.
-
August 10, 2009
Bird flu survivors could face brain disease risk
WASHINGTON (Reuters) - Survivors of bird flu and perhaps other influenza viruses may not be out of the woods once the fever and cough are gone - animal studies suggest the virus may damage the brain and cause Alzheimer's and Parkinson's disease.
-
July 30, 2009
HIV-infected women often skip Pap tests: study
NEW YORK (Reuters Health) - Even though they are at increased risk of cervical cancer, nearly one in four HIV-positive women in the US who were recently interviewed had not had a Pap test to look for cervical cancer in the previous year, investigators found.
-
July 29, 2009
Pap tests don't curb cancer rates in young women
NEW YORK (Reuters Health) - Cervical cancer screening with Pap smears in women between 20 and 24 years of age has little or no impact on rates of cervical cancer up to age 30, a new study suggests.
-
July 23, 2009
Vaccine struggle embodies U.S. health reform battle
WASHINGTON (Reuters) - The confusion surrounding adult vaccination help illustrates some of the big problems looming for Congress as it struggles with healthcare reform legislation, doctors and health officials said on Wednesday.
-
July 9, 2009
WHO clears Cervarix vaccine for developing world
LONDON (Reuters) - GlaxoSmithKline's cervical cancer vaccine Cervarix has won a green light from the World Health Organisation (WHO) for use in developing countries, although how the shot will be paid for has yet to be resolved.
-
July 7, 2009
Cervarix effective against more viruses
LONDON (Reuters) - As well as protecting against the two most common cervical cancer-causing viruses, the vaccine Cervarix also provides protection against the next three most common cancer-causing virus types, according to a study published in Tuesday's issue of The Lancet.
-
July 6, 2009
HPV shot too costly for the Netherlands: study
NEW YORK (Reuters Health) - The vaccine against the virus responsible for most cases of cervical cancer would have to be a lot cheaper in order for it to be cost effective in the Netherlands, and probably in other countries where cases of cervical cancer and deaths due to the disease are relatively low, Dutch researchers report.
-
June 24, 2009
Europe aims to reduce cancer deaths by 15 pct by 2020
BRUSSELS (Reuters) - Europe is aiming to reduce its cancer deaths by 15 percent by 2020 and needs to double screenings to prevent mortality rates climbing as the population ages, the EU's health chief said on Wednesday.
-
June 2, 2009
Cervical cancer vaccine benefits older women: study
WASHINGTON (Reuters) - Older women can benefit just as much as younger women from Merck's Gardasil vaccine against cervical cancer, researchers in Colombia reported on Monday.
-
May 26, 2009
Most mothers oppose cancer vaccine for daughters
NEW YORK (Reuters Health) - New research suggests that most U.S. mothers who have a daughter between 9 and 12 years old do not intend to have her vaccinated against human papillomavirus (HPV), the cause of almost all cases of cervical cancer.
-
May 20, 2009
Stem cells "seek and destroy" cancer cells: study
CHICAGO (Reuters) - Genetically engineered stem cells from bone marrow showed promise as a potential new way to deliver a cancer-killing protein to tumors, British researchers said on Tuesday.
-
May 15, 2009
Wart virus makes for less deadly cancer: study
WASHINGTON (Reuters) - A wart virus best known for causing cervical cancer may make for a less-deadly kind of head and neck cancer, researchers reported on Thursday.
-
May 13, 2009
Abnormal cells in cervix raise cancer risk
CHICAGO (Reuters Life!) - A woman's age and the type of treatment she gets may play a big role in the risk that abnormal cells on the cervix will return or develop into cervical cancer, U.S. researchers said on Tuesday.
-
May 7, 2009
Mothers' views important in HPV vaccination
NEW YORK (Reuters Health) - Girls are more likely to be vaccinated against the virus that causes cervical cancer when their mothers are prevention-minded, a new study suggests.
-
April 3, 2009
Singapore questions cervical cancer vaccine for teens
SINGAPORE (Reuters) - A Singapore government minister questioned on Friday the effectiveness of cervical cancer vaccination for teenagers and said such prevention sends out a message that teenage sex is condoned by the community.
-
April 2, 2009
Qiagen virus test cuts deaths from cervical cancer
BOSTON (Reuters) - A single test that looks for the virus that causes cervical cancer cut the death rate from the tumor in half, researchers in India reported on Wednesday.
-
March 26, 2009
Male circumcision cuts risk of cancer-causing virus
LONDON (Reuters) - Circumcision protects men from genital herpes and a virus that causes genital warts and cancer but it does not appear to guard against syphilis, U.S. and Ugandan researchers said on Wednesday.
-
March 25, 2009
Lay health workers boost cancer screening rates
NEW YORK (Reuters Health) - Home visits from peers trained as health workers may encourage more low-income Hispanic women to get screened for breast and cervical cancers, a new study suggests.
-
March 23, 2009
Circumcision protects against genital wart virus
NEW YORK (Reuters Health) - A study of nearly 1000 men in three countries has yielded more evidence that circumcision helps protect against infection with human papillomavirus.
-
March 16, 2009
Anal HPV infection clears quickly in women
NEW YORK (Reuters Health) - Human papillomavirus or HPV, which can cause cervical cancer, may also infect the anus -- but the infection appears to resolve relatively quickly, researchers report.
-
December 18, 2008
Male circumcision lowers cervical cancer risk: study
WASHINGTON (Reuters) - Three studies published on Wednesday add to evidence that circumcision can protect men from the deadly AIDS virus and the sexually transmitted virus that causes cervical cancer.
-
December 8, 2008
Nobel winner sees end to AIDS spread within years
STOCKHOLM (Reuters) - A French scientist who shared this year's Nobel Prize for medicine said on Saturday he believed the transmission of AIDS could be eliminated within years.
-
December 3, 2008
Cervical cancer chemo easier on black women: study
NEW YORK (Reuters Health) - Black women with advanced and recurrent cervical cancer tolerate "platinum-based" chemotherapy drugs better than do their white counterparts, according to a pooled data from three studies, researchers report.
-
December 3, 2008
Allergic reactions to Gardasil uncommon: study
LONDON (Reuters) - A study of Merck & Co Inc's cervical cancer vaccine Gardasil found that allergic reactions were uncommon and most young women can tolerate subsequent doses, Australian researchers said on Wednesday.
-
November 13, 2008
Cervical cancer vaccine can protect men from HPV
WASHINGTON (Reuters) - A vaccine designed to protect women and girls from cervical cancer caused by a virus that also causes genital warts may protect men, too, maker Merck and Co reported on Thursday.
-
November 3, 2008
Wart virus caused 25,000 cancers in 5 years
WASHINGTON (Reuters Life!) - The human wart virus HPV caused 25,000 cases of cancer in the United States between 1998 and 2003, including not only cervical cancer but also anal and mouth cancers, the U.S. Centers for Disease Control and Prevention reported on Monday.
-
October 27, 2008
Aggressive vaccine effort could cut cervical cancer
CHICAGO (Reuters) - An aggressive strategy of vaccinating older women against cervical cancer could deliver a crippling blow against the disease, cutting rates for that type of cancer in half for women through age 45, U.S. researchers said on Saturday.
-
October 24, 2008
British doctor chooses Gardasil shot over Cervarix
LONDON (Reuters) - Even though Britain chose GlaxoSmithKline's Cervarix for its cervical cancer vaccine program, many British doctors pick Merck and Co's Gardasil for their own daughters, a well-known physician said on Friday.
-
October 22, 2008
Few adverse reactions to cervical cancer vaccine
WASHINGTON (Reuters) - Girls and young women given Merck and Co's Gardasil vaccine to prevent cervical cancer were not any more likely than usual to faint, have an allergic reaction, blood clot, or other adverse reaction, federal officials said on Wednesday.
-
October 10, 2008
HPV infection rates similar in men and women
NEW YORK (Reuters Health) - Although men are at high risk of acquiring human papillomavirus (HPV) infections, most last no more than a year, about the same time this sexually transmitted disease persists in women, researchers report in The Journal of Infectious Diseases.
-
October 9, 2008
Quarter of adolescent U.S. girls received HPV
WASHINGTON (Reuters) - A quarter of girls aged 13 to 17 in the United States received Merck & Co's Gardasil vaccine last year to protect against the human papillomavirus, which causes cervical cancer, the U.S. government said on Thursday.
-
October 6, 2008
Nobel medicine prize reopens old AIDS dispute
WASHINGTON (Reuters) - The decision announced Monday to award the Nobel Prize for Medicine to Luc Montagnier and Francoise Barre-Sinoussi for their discovery of the AIDS virus was perceived by many to be a snub to U.S. virologist Dr. Robert Gallo, and reopened an old dispute over the research.